Cardiology

Results from host-reduce-polytech-ACS trial reported

A randomized clinical trial found that drug-eluting stents (DES) with durable polymers are non-inferior to DES with biodegradable polymers in patients with acute coronary syndrome (ACS).

Cardiology

One year results from the REDUCE trial reported

Results from the prospective, multicenter, randomized investigator-initiated REDUCE trial were reported today at the 29th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular ...

Cardiology

Race, gender and socioeconomic factors impact PCI outcomes

A first-of-its-kind study discovered that women and minorities who underwent a percutaneous coronary intervention (PCI) are at a greater risk of experiencing recurrent cardiac events within the first year after their procedure ...

Cardiology

Risks, benefits of cangrelor consistent in angina, ACS

(HealthDay)—For patients with stable angina (SA) or acute coronary syndrome (ACS), the benefits and risks of cangrelor are consistent, according to a study published in the Sept. 26 issue of JACC: Cardiovascular Interventions.

Cardiology

Guidelines updated on duration of dual antiplatelet Tx in CAD

(HealthDay)—The American College of Cardiology and the American Heart Association Task Force on Clinical Practice Guidelines has updated the recommendations regarding duration of dual antiplatelet therapy (DAPT) for patients ...

page 1 from 6